U.S. Markets open in 5 hrs 9 mins

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
204.95-4.45 (-2.13%)
At close: 4:00PM EDT
People also watch
ALXNREGNBIIBVRTXCELG
  • A
    Ashley
    Ashley
    WOW is all I can say right now. The dork has been absolutely killing it for me recently. Check out this free service at the-stock*dork .
  • A
    Anonymous
    Anonymous

    MEGA OPP on this one ...
    SLNO (MC $25 M) BLOCKBUSTER in Phase 3 /Rare Disease +Orphan Status /$2+ BILLION Market /NO Debt = REAL Unknown low float stock with 1000% upside Potential and more .Next billion dollar rare disease company like SRPT here .GLTA

    Soleno therapeutics (SLNO)

    Market Cap $25 Million
    Cash: $8 Million
    Price $0.51

    Shares Out: 47.6 Million ( 36 Million shares held by Insiders & Institutions)

    Initiating Coverage June 26, 2017
    http://www.lifescicapital.com/wp-content/uploads/Soleno.pdf

    •Company expects to initiate pivotal Phase III clinical trial by year-end 2017; will take approximately 9-12 months to complete

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017.

    Market Opportunity for PWS is Substantial.

    While the lack of approved treatments for PWS alone make it difficult to assess the market, sales of Pfizer’s (NYSE: PFE)
    Genotrop in (somatropin) can provide some insight despite being indicate for PWS, in addition to, growth failure due to growth hormone deficiency(GHD),Turner syndrome,idiopathic short stature,and small for gestational age.This product achieved its highest revenue in 2008,with worldwide sales of approximately $900 million.While somatropin has been proven to improve growth and body composition, it does not affect the key disease component of hyperphagia and use is associated with substantial risk. Soleno is developing DCCR for the treatment of PWS,to help address the unmet need of this patient population. To assess the potential of DCCR for PWS, we performed a scenario analysis, which indicates that annual sales could be in the range of $1.1 billion given a moderate price point and 50% market penetrance.

  • C
    Charles
    Charles

    It's a funny thing about life; http://dataunion.tistory.com/2254

    [2016-MAY] Illumina NASDAQ : ILMN Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.8 In other words, the correlation coefficient of the other stock
    dataunion.tistory.com
  • S
    Sophia
    Sophia

    Sick of getting crushed in the markets all the time. One free service that really helped my trading is https://awesomestockadvice1.blogspot.com/. See what they have to offer at https://awesomestockadvice1.blogspot.com/ .

    Penny Stocks
    awesomestockadvice1.blogspot.com
  • M
    Mackenzie
    Mackenzie
    Things seem to be getting overextended for ILMN. awe-some*sto-cks recently alerted this company i think. google them.
  • A
    Anonymous
    Anonymous
    ILMN stock keeps pushing to new highs, yet the insiders keep selling the stock during the climb up. Check out the awarded options and the automatic sales. Seems to me if the stock was reasonably priced, then the inside officers would want to hold on for a bigger profit later.
  • A
    Alyssa
    Alyssa

    I think ILMN might have reached its upward limit and that a pullback may be possible. if you guys have questions you should ask https://hotstocks123.blogspot.com. They often respond to my emails which is helpful.

    Hot Stocks
    hotstocks123.blogspot.com.
  • G
    Guru
    Guru
    stock has rocketed from a low of 120 to more than 200 in a matter of 9 months. What has changed materially for ILMN to add so much to it's market cap?
  • M
    Marc
    Marc
    $GILD conversation

    Wall Street Best Biotech Investment Advisor Portfolio Soars to All-Time Highs $KITE $GILD $AMGN $BIIB $BLUE $ISRG $ILMN $VRTX https://www.youtube.com/watch?v=3EDC8ZojUik

    Wall Street Best Biotech Investment Advisor Portfolio Soars to All-Time Highs
    https://stockmarketLIVE.TV stock market Live News. Live streaming trading. Live stock forecasts. Trading Courses. Live Earnings Calls. Markets Live Analysis....
    www.youtube.com
  • M
    Marc
    Marc
    $KITE conversation

    Truth Behind Kite Pharma Buyout and Vetr Stock Ratings SCAM $KITE $GILD $VRTX $ACAD $BIIB $BLUE $ILMN https://www.youtube.com/watch?v=W6vUZDabB1s

    Truth Behind Kite Pharma Buyout and Vetr Stock Ratings SCAM
    https://stockmarketLIVE.TV stock market Live News. Live streaming trading. Live stock forecasts. Trading Courses. Live Earnings Calls. Markets Live Analysis....
    www.youtube.com
  • S
    Shirley
    Shirley

    I also received an alert for $ILMN from http://jcharlesassets.com/opiant-pharmaceuticals/?s=ILMN , any ideas? Investing making money. "hhse"

    Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
    We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
    jcharlesassets.com
  • A
    Alajuela
    Alajuela
    Any guesses of where it'll move from here?
  • G
    Gerald
    Gerald
    Earnings easily topped expectations.
  • a
    angmed1
    angmed1
    AAPL and ILMN, romantic ideal couple.
  • C
    Crecy
    Crecy
    Nice move up. OT Must see AVEO...close to moving up higher...come to the Yahoo message board. Rx for Renal cancer-Tivozanib- Recommended for Approval. Date for Approval end Aug...SOON.
  • G
    Guru
    Guru
    down after hours?
  • j
    joe
    joe
    Test kit is huge deal should bring significant move.
  • P
    Pharmaheroooooo
    Pharmaheroooooo
    (AXSM) Market Cap $90 M/Cash $55 M / 5x BIG Phase 3 programs in various indications targeting large Markets with first results in Q3 2017 =20 BAGGER ..FANTASTIC OPPORTUNITY !

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $90 million and $55 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $90 Million
    Cash: $55 Million(cash runway into the first quarter of 2019.)
    Price:$3.90

    Shares Out: 23.5 Million

    Aegis Capital has reiterated a ‘Buy’ rating and price target of $20 on Axsome Therapeutics (NASDAQ: AXSM) after the company reported financial results for the quarter ended March 31, 2017. The analyst noted that although Axsome reported revenue in-line with consensus estimates, the focus remains on upcoming catalysts such as the company’s ongoing clinical trials. Since February 2017, the company’s AXS-05 has received fast track designation from the FDA for the treatment of Alzheimer’s disease (AD) agitation and treatment resistant depression (TRD). Topline data from the TRD treatment study is expected in the first quarter of 2018. Additionally, Axsome is developing AXS-02 in three separate phase 3 clinical programs, including chronic low back pain associated with modic changes and complex regional pain syndrome, with interim data expected in the fourth quarter of 2017, as well as knee osteoarthritis associated with bone marrow lesions, with interim data expected in the third quarter of 2017.
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    ILMN is down -4.92% to 168.94
  • B
    Bay Area
    Bay Area
    Wait, didn't this scam missed earnings and downwardly revised the guidance big time. Oh I forgot we are in the bubble so all that doesn't matter. But wait what will happen to #$%$ stocks like these when bubble finally goes bonker? It may happen starting Monday. Nasdaq wouldn't stop until it has falled 20-30% or more. Some are saying 80% drop, worst ever after 1929 and 2000.